查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1924761

手術機器人市場按組件、應用和最終用戶分類 - 全球預測 2026-2032 年

Surgical Robotics Market by Component, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，手術機器人市場價值將達到 97.8 億美元，到 2026 年將成長至 106.9 億美元，到 2032 年將達到 185.2 億美元，年複合成長率為 9.54%。

關鍵市場統計數據
基準年 2025 97.8億美元
預計年份：2026年 106.9億美元
預測年份 2032 185.2億美元
複合年成長率 (%) 9.54%

在外科機器人技術正處於臨床、技術和商業性轉折點之際，策略性應用正在重塑其應用格局和競爭地位。

手術機器人領域正處於戰略轉折點，其驅動力源於器械技術進步、軟體智慧以及醫療系統優先事項的融合。臨床團隊尋求能夠減少手術差異、改善治療效果並縮短復原時間的工具，而醫院管理者則優先考慮可預測的營運經濟效益、工作流程整合以及病患吞吐量的顯著提升。同時，小型化、增強觸覺回饋和雲原生分析等技術的進步正在拓展機器人系統及其周邊設備的臨床應用範圍。這些技術變革輔以不斷發展的報銷和法規結構，這些框架越來越重視基於證據的價值論證，以及一個強調總體擁有成本和全生命週期支持的服務供應商生態系統。

臨床實踐、平台模組化和商業服務模式的變革性變化正在重新定義手術機器人如何創造臨床和經濟價值。

從手術室到企業層面，外科機器人領域正經歷一系列相互關聯的變革。首先，臨床實踐正朝著特定手術流程的自動化和先進的器械操控性方向發展，擴大了機器人輔助手術能夠帶來顯著益處的手術範圍。同時，單一整體式的平台正向模組化系統和器械生態系統轉變，使醫院能夠根據病例組合和資金限制靈活擴展手術能力。其次，軟體正成為關鍵的差異化因素。先進的影像融合技術、人工智慧驅動的決策支援工具和手術分析技術，能夠提高手術結果的可預測性，並加快外科醫生資格認證流程。

關稅驅動的成本壓力和供應鏈調整如何重塑外科機器人領域的採購、製造本地化和生命週期策略

關稅的徵收或貿易政策調整會影響醫療設備，進而顯著改變整個手術機器人生態系統的採購決策、供應鏈結構和定價策略。關稅變動不僅直接對資本設備造成價格壓力，還會間接影響手術經濟效益的關鍵要素—器械、組件和耗材的成本。醫院和門診中心正透過推遲設備更新周期、在擴建過程中優先選擇成本較低的系統，或與供應商協商更嚴格的服務和耗材定價來應對這些成本壓力。

針對不同細分市場的洞察，將產品模組化、臨床證據和客製化服務模式結合，以應對不同專科和臨床環境下的不同採用模式。

細分分析揭示了不同產品類型、臨床應用、終端使用者環境和組件類別的需求趨勢和採用障礙。這些差異應為制定有針對性的市場進入策略提供基礎。在產品層面，儀器和配件、服務以及系統各自的採用曲線各不相同。儀器和配件是耗材收入的主要來源，需要持續供應。服務包括諮詢以及安裝、培訓、維護和支持，這些對於順利的臨床過渡至關重要。系統是資本密集核心資產，也是臨床專案的基礎。應用細分錶明，不同專科的臨床價值提案有所不同。一般外科和婦科手術優先考慮效率和縮短住院時間，神經外科強調精準性和影像整合，整形外科專注於對位和植入放置，泌尿系統則需要微創方法來縮短恢復時間。終端使用者細分錶明，門診手術中心、醫院和專科診所在採購和營運重點方面存在差異。門診中心重視低准入成本和快速週轉；醫院重視企業整合和多學科效用；專科診所重視針對特定手術流程的最佳化以及可預測的單例經濟效益。組件細分突顯了硬體、服務和軟體之間的相互關係。硬體性能必須由服務提供支持，包括諮詢、安裝、培訓、維護和支援。軟體也擴大透過分析、影像處理和工作流程編排來釋放價值。

區域趨勢要求制定量身定做的監管、報銷和本地化策略，以確保全球臨床應用和計畫的永續性。

手術機器人領域的區域發展趨勢受各地區管理體制、報銷結構和醫療服務模式差異的影響，這些差異也影響企業的擴張重點和夥伴關係策略。在美洲，醫院基礎設施的投資以及人們對微創手術日益成長的興趣，推動了對能夠展現手術效率和良好圍手術全期效果的系統和器械的需求。尤其是在美國，完善的公立和私人醫療支付體系獎勵那些能夠顯著提升臨床療效和手術效率的系統和器械，這促使製造商投資於上市後監測和真實世界數據收集，以支持醫院的採購決策。在拉丁美洲，機器人技術的部署通常遵循分階段的方法，由領先的都市區醫院率先部署先進平台，然後發展成為區域培訓中心。

平台現有企業、專業創新者和軟體主導新進業者將如何透過夥伴關係和以結果為導向的服務模式攜手塑造競爭地位

隨著老牌醫療設備製造商、機器人專家和新興軟體主導企業的融合，外科手術機器人領域的競爭格局正在改變。擁有整合平台的市場領導受益於規模經濟、成熟的實施經驗以及跨多個專科的臨床檢驗，但他們也在尋求模組化產品，以滿足預算有限的買家和特定手術應用的需求。專業機器人公司通常透過特定領域的創新來脫穎而出，例如單一手術系統和高度微型化的器械，並透過與進行大量手術的領先醫療中心密切合作來加速臨床應用。軟體主導公司透過提供可添加到現有硬體的先進影像融合技術、術中導航和手術分析功能，重新定義了價值，從而創造了新的服務和訂閱收入來源。

給經營團隊的可操作建議：透過整合模組化產品開發、全面服務交付和實證商業模式來加速產品推廣應用

致力於加速產品推廣並鞏固市場地位的領導者應優先考慮整合產品設計、服務和實證實踐的整合策略。首先，產品藍圖應強調模組化架構和互通軟體，從而實現增量投資並輕鬆整合到醫院的IT和影像生態系統中。這種方法可以降低醫院在多個醫療部門間最大化資產利用率的應用障礙。其次，建立包含諮詢、實施和培訓以及維護和支援在內的綜合服務包，可以最大限度地減少臨床摩擦，並加快首例病例的開展。有效的培訓計畫和認證流程可以減少結果的差異性，並培養能夠推動組織更廣泛應用的臨床領導者。第三，投資建設能夠捕捉手術結果和營運指標的數據平台對於支援與支付方的合作以及組織價值評估至關重要。真實世界的臨床數據對於協商有利的採購條款以及區分臨床和經濟價值提案至關重要。

本研究採用嚴謹的混合方法調查方法，結合相關人員訪談、二手證據和情境分析，檢驗其對技術、服務和政策的影響。

本分析結合了第一手和第二手調查方法，以確保對外科機器人領域形成全面、多角度的觀點。第一手研究包括與臨床、採購和工程部門的相關人員進行結構化對話，以收集有關推廣應用促進因素、營運障礙和服務優先事項的第一手資訊。此外，還對醫院管理人員、多專科外科醫生以及門診和專科診所營運經理進行了深入訪談，以確定臨床應用案例的優先順序並驗證培訓需求。第二手研究則依賴監管文件、臨床文獻和公開訊息，以支持技術趨勢和合作活動，並檢驗不斷變化的報銷框架和監管路徑。

策略重點的關鍵整合，著重於臨床證據、互通性和穩健的服務模式，以支持外科機器人領域的持續成長。

手術機器人技術正從少數基礎平台主導的時代邁向一個更加多元化的生態系統，其特點是模組化硬體、智慧軟體和整合提案。臨床需求在各個專科領域日益多樣化，醫療系統也越來越注重從臨床結果和營運價值觀點方面評估技術。隨著關稅和價值鏈趨勢的演變，採購決策變得更加複雜，製造商正致力於在地化、彈性價格設定和建立更完善的服務網路。能夠將技術優勢轉化為可預測的臨床效益、提供擴充性的培訓和維護服務，並能向醫院採購委員會清楚闡述整體擁有成本的公司，才能最終獲得成功。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 手術機器人市場（依組件分類）

  • 硬體
  • 服務
    • 諮詢
    • 安裝和培訓
    • 維護和支援
  • 軟體

第9章 依應用分類的手術機器人市場

  • 一般外科
  • 婦科手術
  • 神經外科
  • 整形外科手術
  • 泌尿系統

第10章 以最終用戶分類的手術機器人市場

  • 門診手術中心
  • 醫院
  • 專科診所

第11章 各地區手術機器人市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章 手術機器人市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 各國手術機器人市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章：美國手術機器人市場

第15章：中國手術機器人市場

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Accuray Incorporated
  • Asensus Surgical, Inc.
  • Auris Health, Inc.
  • Corindus Vascular Robotics
  • Curexo Technology Corporation
  • Globus Medical, Inc.
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • Mazor Robotics Ltd.
  • Medrobotics Corporation
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Renishaw plc
  • Siemens Healthineers AG
  • Smith & Nephew plc
  • Stryker Corporation
  • Think Surgical, Inc.
  • Tinavi Medical Technologies Co., Ltd.
  • TransEnterix, Inc.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-7A380DA7C485

The Surgical Robotics Market was valued at USD 9.78 billion in 2025 and is projected to grow to USD 10.69 billion in 2026, with a CAGR of 9.54%, reaching USD 18.52 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 9.78 billion
Estimated Year [2026] USD 10.69 billion
Forecast Year [2032] USD 18.52 billion
CAGR (%) 9.54%

A strategic introduction that frames the clinical, technological, and commercial inflection points reshaping adoption and competitive positioning in surgical robotics

The surgical robotics sector stands at a strategic inflection point driven by converging advances in instrumentation, software intelligence, and health-system priorities. Clinical teams are seeking tools that reduce variability, improve outcomes, and shorten recovery, while hospital administrators prioritize predictable operational economics, workflow integration, and demonstrable improvements in patient throughput. Concurrently, engineering progress in miniaturization, enhanced haptic feedback, and cloud-native analytics is expanding the clinical envelope of robotic systems and peripherals. These technological shifts are complemented by evolving reimbursement and regulatory frameworks that are increasingly receptive to evidence-based demonstrations of value, and by an ecosystem of service providers that emphasize total-cost-of-ownership and lifecycle support.

Against this backdrop, commercial strategies are diversifying. Some manufacturers are deepening relationships with device-agnostic service providers to improve installation and training throughput, while others are integrating advanced software capabilities to capture clinical and operational data that informs continuous improvement. New entrants are focusing on niche applications and lower-cost systems to address ambulatory and specialty clinic use cases, while established players continue to push integrative platforms that bundle hardware, software, and long-term service agreements. As a result, stakeholders must balance near-term clinical adoption goals with longer-term platform and ecosystem plays that shape competitive differentiation and durable revenue streams.

Transformative shifts in clinical practice, platform modularity, and commercial service models that are redefining how surgical robotics deliver clinical and economic value

The landscape for surgical robotics is being transformed by a set of interrelated shifts that extend from the operating room to the enterprise level. First, clinical practice is moving toward procedure-specific automation and enhanced instrument dexterity, which is broadening the scope of procedures where robotic assistance can offer measurable benefits. This clinical broadening is accompanied by a shift from singular monolithic platforms to modular systems and instrument ecosystems that allow hospitals to scale capabilities according to case mix and capital constraints. Second, software is becoming a primary differentiator: advanced imaging fusion, AI-driven decision aids, and procedural analytics are enabling more predictable outcomes and more rapid credentialing pathways for surgeons.

Third, the commercial model is evolving as providers demand flexible pricing, outcome-based contracting, and managed-service offerings that mitigate upfront capital intensity. This has encouraged service-oriented business models that bundle consulting, installation and training, and maintenance and support to improve time-to-value. Fourth, regulatory pathways and payer engagement are aligning around real-world evidence and post-market surveillance, creating incentives for manufacturers to invest in longitudinal data capture and outcomes research. Finally, supply chain resilience and localization pressures are prompting manufacturers to reassess sourcing strategies and partnerships, accelerating regional manufacturing and localized support networks to improve responsiveness and reduce operational risk. Together, these shifts are creating opportunities for agile players that can synchronize product innovation with services, reimbursement strategies, and data-driven value propositions.

How tariff-induced cost pressures and supply chain adjustments are reshaping procurement, manufacturing localization, and lifecycle strategies across surgical robotics

The imposition of tariffs and trade policy adjustments affecting medical devices can materially alter procurement decisions, supply chain architectures, and pricing strategies across the surgical robotics ecosystem. Tariff changes create both immediate price pressures for capital equipment and secondary impacts on the cost of instruments, subassemblies, and consumables that are critical to procedural economics. Hospitals and ambulatory centers respond to such cost pressures by delaying capital replacement cycles, prioritizing lower-cost systems for expansion, or negotiating more rigorous service and consumable pricing with vendors.

Moreover, tariffs influence strategic sourcing: manufacturers may accelerate localization of manufacturing, shift to alternative component suppliers from tariff-exempt jurisdictions, or increase vertical integration to insulate margins. These responses require capital and operational adjustments, including requalification of suppliers and recalibration of inventory strategies to mitigate lead-time variability. In parallel, service providers and systems integrators may see increased demand for installation, retrofit, and upgrade services as buyers seek to extend the useful life of existing assets rather than pursue costly replacements.

Finally, certainty and transparency in supply chain cost structures become a competitive advantage. Companies that can articulate clear mitigation strategies, long-term service commitments, and flexible pricing models will be better positioned to retain hospital customers and specialty clinics through periods of tariff-driven cost volatility. Clear communication of total-cost-of-ownership, lifecycle support, and evidence of supply chain resilience will influence procurement committees and clinical leaders who must balance clinical performance against constrained capital budgets.

Segment-specific insights that align product modularity, clinical evidence, and tailored service models to differentiated adoption patterns across specialties and care settings

Segmentation analysis reveals differentiated demand dynamics and adoption barriers across product types, clinical applications, end-user settings, and component categories, and these distinctions should inform targeted go-to-market strategies. Within the product dimension, instruments and accessories, services, and systems each follow distinct adoption curves: instruments and accessories often drive consumable revenue and require tight supply continuity, services encompass consulting as well as installation and training and maintenance and support that are essential for a smooth clinical transition, and systems represent the capital-intensive hub around which clinical programs are built. Application segmentation indicates that clinical value propositions vary by specialty: general surgery and gynecological surgery typically prioritize efficiency and reduced length of stay; neurological surgery emphasizes precision and imaging integration; orthopedic surgery focuses on alignment and implant placement; and urological surgery seeks minimally invasive approaches that shorten recovery. End-user segmentation shows divergent procurement and operational priorities across ambulatory surgical centers, hospitals, and specialty clinics, where ambulatory centers often demand lower entry cost and rapid throughput, hospitals prioritize enterprise integration and cross-disciplinary utility, and specialty clinics seek procedure-specific optimization and predictable per-case economics. Component segmentation highlights the interplay between hardware, services, and software, where hardware performance must be supported by services that include consulting and installation and training and maintenance and support, and software increasingly unlocks value through analytics, imaging, and workflow orchestration.

Understanding these segments enables more precise messaging and product design. Commercial teams should tailor clinical evidence packages to specialty-specific outcome measures, structure service agreements that reflect the differentiated training needs of ambulatory and hospital settings, and ensure supply chain continuity for instruments that drive recurring revenue. Product development should prioritize modularity in systems to permit phased upgrades, and software roadmaps should align with hospital IT priorities to ease integration and data governance. Strategic partnerships with clinical societies, training centers, and third-party service providers can accelerate adoption within targeted segments by addressing both technical and operational barriers.

Regional dynamics that require tailored regulatory, reimbursement, and localization strategies to capture clinical adoption and long-term program sustainability worldwide

Regional dynamics in surgical robotics are shaped by distinct regulatory regimes, reimbursement structures, and healthcare delivery models, and these differences inform expansion priorities and partnership strategies. In the Americas, investment in hospital infrastructure and a growing focus on minimally invasive procedures drive demand for systems and instruments that can demonstrate procedural efficiency and favorable perioperative outcomes. The United States, in particular, has a sophisticated private and public payer environment that rewards evidence of improved clinical outcomes and procedural throughput, motivating manufacturers to invest in post-market studies and real-world data collection to support hospital procurement decisions. Latin American adoption often follows a phased approach where leading hospitals in urban centers adopt advanced platforms and subsequently become regional training hubs.

Across Europe, the Middle East & Africa, regulatory harmonization efforts coexist with country-level reimbursement variability, requiring nuanced market entry strategies. European health systems emphasize cost-effectiveness and tender-based procurement, which favors solutions that can demonstrate clear total-cost-of-ownership advantages and strong service frameworks. The Middle East and Africa regions often prioritize rapid capability buildup and may favor bundled service and training offerings to accelerate clinical adoption across nascent programs. In Asia-Pacific, heterogeneity ranges from highly advanced markets with robust innovation ecosystems and strong local manufacturing capabilities to emerging markets where affordability and distributorship models dominate. Several Asia-Pacific countries are investing in localized manufacturing and clinical training centers, creating opportunities for partnerships that blend technology transfer with local service provision. Across regions, companies that adapt pricing models, localize support, and build evidence aligned with payer expectations will accelerate uptake and long-term program sustainability.

How competitive positioning is shaped by platform incumbency, specialized innovators, and software-driven entrants collaborating through partnerships and outcome-focused service models

Competitive dynamics in the surgical robotics space are evolving as established medical device manufacturers, focused robotics specialists, and software-first entrants converge. Market leaders with integrated platforms benefit from scale, installed base, and clinical validation across multiple specialties, but they face pressure to modularize offerings to address budget-constrained buyers and procedure-specific use cases. Specialist robotics firms differentiate through domain-focused innovations, such as single-procedure systems or highly miniaturized instruments, and often accelerate clinical adoption by aligning closely with high-volume centers of excellence. Software-focused companies are redefining value by delivering advanced imaging fusion, intraoperative guidance, and procedural analytics that can be layered onto existing hardware, creating new service and subscription revenue streams.

Partnerships and alliances are a defining feature of competitive strategy, with collaboration between device makers, imaging companies, and health systems enabling tighter integration of clinical workflows. Additionally, M&A and strategic investments continue to reconfigure the competitive map as companies seek to fill capability gaps in software, navigational systems, and service delivery. For shorter time-to-value, firms that invest in robust training programs, scalable maintenance networks, and demonstrated outcomes data will be better positioned to secure long-term service agreements and recurring revenue. Moreover, companies that offer transparent procurement models, flexible financing, and outcome-aligned contracts will gain traction with hospital procurement teams focused on predictable financial performance and clinical risk mitigation.

Actionable recommendations for executives to align modular product development, comprehensive service delivery, and evidence-driven commercial models for accelerated adoption

Leaders seeking to accelerate adoption and strengthen market positions should prioritize a coordinated strategy that links product design, services, and evidence generation. First, product roadmaps should emphasize modular architectures and interoperable software that enable phased investments and easier integration into hospital IT and imaging ecosystems. This approach reduces barriers to adoption for hospitals that need to maximize asset utilization across multiple specialties. Second, establish comprehensive service bundles that include consulting, installation and training, and maintenance and support to minimize clinical friction and accelerate time-to-first-case. Effective training programs and credentialing pathways will reduce variability in outcomes and foster clinician champions who drive broader institutional adoption. Third, invest in data platforms that capture procedural outcomes and operational metrics to support payer engagement and institutional value assessments. Real-world evidence will be critical for negotiating favorable procurement terms and for differentiating the clinical and economic value proposition.

Fourth, build supply chain resilience through strategic supplier diversification, localized manufacturing where feasible, and inventory strategies that mitigate tariff and logistical risks. Fifth, pursue targeted partnerships with clinical centers of excellence, imaging providers, and healthcare systems to co-develop protocols and to accelerate clinical validation across priority applications. Finally, adopt flexible commercial models, including managed-service agreements and outcome-based pricing pilots, to align incentives with health-system goals and reduce procurement friction. Executing these recommendations requires cross-functional coordination across R&D, commercial, regulatory, and operations teams to ensure that product capabilities, service delivery, and evidence generation are mutually reinforcing.

A rigorous mixed-method research approach integrating stakeholder interviews, secondary evidence, and scenario analysis to validate technology, service, and policy implications

This analysis synthesizes primary and secondary research methods to ensure a robust, multi-dimensional perspective on the surgical robotics landscape. Primary research included structured engagements with stakeholders across clinical, procurement, and engineering functions to capture firsthand perspectives on adoption drivers, operational barriers, and service priorities. These engagements were complemented by in-depth interviews with hospital administrators, surgeons across multiple specialties, and heads of ambulatory and specialty clinic operations to validate clinical use-case prioritization and training needs. Secondary research drew on regulatory filings, clinical literature, and public disclosures to corroborate technology trends and partnership activity, and to assess evolving reimbursement frameworks and regulatory pathways.

Analytical approaches employed technology and application mapping to identify product and clinical fit, scenario analysis to model procurement and tariff sensitivities, and value-chain mapping to highlight strategic levers for supply chain resilience and service delivery. Cross-validation techniques ensured alignment between interview insights and documented evidence, reducing bias and improving the reliability of thematic conclusions. Limitations include the variability of healthcare reimbursement across jurisdictions and the evolving nature of regulatory guidance, which underscore the importance of ongoing data collection and local validation when applying these insights to specific market-entry or expansion decisions. Where appropriate, the methodology emphasizes adaptive strategies that can be tailored to local regulatory and payer contexts to ensure relevance and applicability.

Conclusive synthesis of strategic priorities emphasizing clinical evidence, interoperability, and resilient service models that underpin sustainable growth in surgical robotics

Surgical robotics is transitioning from an era dominated by a few foundational platforms to a more pluralistic ecosystem characterized by modular hardware, intelligent software, and integrated service propositions. Clinical demand is diversifying across specialties, and health systems increasingly assess technology through the twin lenses of clinical outcomes and operational value. Tariff and supply chain dynamics add complexity to procurement decisions, prompting manufacturers to pursue localization, flexible pricing, and stronger service networks. Successful players will be those that can translate technological advantage into predictable clinical benefit, deliver scalable training and maintenance, and provide transparent total-cost-of-ownership narratives that resonate with hospital procurement committees.

Looking ahead, the companies that combine targeted clinical evidence, interoperability-focused product design, and resilient service architectures will be best positioned to capture long-term value. Strategic emphasis on partnerships, localized support, and data-driven post-market surveillance will not only de-risk adoption but also create differentiated service revenue streams. In sum, surgical robotics offers compelling opportunities for innovation and improved patient care, but realizing that potential requires integrated strategies that align product capability, clinical validation, and sustainable commercial models to meet the operational realities of care delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Robotics Market, by Component

  • 8.1. Hardware
  • 8.2. Services
    • 8.2.1. Consulting
    • 8.2.2. Installation & Training
    • 8.2.3. Maintenance & Support
  • 8.3. Software

9. Surgical Robotics Market, by Application

  • 9.1. General Surgery
  • 9.2. Gynecological Surgery
  • 9.3. Neurological Surgery
  • 9.4. Orthopedic Surgery
  • 9.5. Urological Surgery

10. Surgical Robotics Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
  • 10.3. Specialty Clinics

11. Surgical Robotics Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Surgical Robotics Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Surgical Robotics Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Surgical Robotics Market

15. China Surgical Robotics Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. Accuray Incorporated
  • 16.6. Asensus Surgical, Inc.
  • 16.7. Auris Health, Inc.
  • 16.8. Corindus Vascular Robotics
  • 16.9. Curexo Technology Corporation
  • 16.10. Globus Medical, Inc.
  • 16.11. Intuitive Surgical, Inc.
  • 16.12. Johnson & Johnson
  • 16.13. Mazor Robotics Ltd.
  • 16.14. Medrobotics Corporation
  • 16.15. Medtronic plc
  • 16.16. MicroPort Scientific Corporation
  • 16.17. Renishaw plc
  • 16.18. Siemens Healthineers AG
  • 16.19. Smith & Nephew plc
  • 16.20. Stryker Corporation
  • 16.21. Think Surgical, Inc.
  • 16.22. Tinavi Medical Technologies Co., Ltd.
  • 16.23. TransEnterix, Inc.
  • 16.24. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL ROBOTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL ROBOTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL ROBOTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES SURGICAL ROBOTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA SURGICAL ROBOTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL ROBOTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY CONSULTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY INSTALLATION & TRAINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY INSTALLATION & TRAINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY INSTALLATION & TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY NEUROLOGICAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY NEUROLOGICAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY UROLOGICAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY UROLOGICAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY UROLOGICAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS SURGICAL ROBOTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA SURGICAL ROBOTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 76. MIDDLE EAST SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. AFRICA SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 81. AFRICA SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 92. ASEAN SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. GCC SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GCC SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 97. GCC SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 98. GCC SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. GCC SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPEAN UNION SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPEAN UNION SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPEAN UNION SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. BRICS SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. BRICS SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 107. BRICS SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. G7 SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. G7 SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 112. G7 SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 113. G7 SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. G7 SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. NATO SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. NATO SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 117. NATO SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 118. NATO SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. NATO SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL SURGICAL ROBOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. UNITED STATES SURGICAL ROBOTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 122. UNITED STATES SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 123. UNITED STATES SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 124. UNITED STATES SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. UNITED STATES SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. CHINA SURGICAL ROBOTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 127. CHINA SURGICAL ROBOTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 128. CHINA SURGICAL ROBOTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 129. CHINA SURGICAL ROBOTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. CHINA SURGICAL ROBOTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)